Internal Medicine · Rego Park, NY
NPI
1790750859
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9811 Queens Blvd, Suite 1e
Rego Park, NY, 11374
Phone (718) 830-0400
Groups this clinician bills Medicare through
Medicare paid, 2024
$346K
4,805 services
Medicare patients, 2024
491
Average age 76
Drug cost, 2024
$4.6M
30,253 prescriptions
Company payments, 2025
$3,174
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Naum Meyerovich was code 99213 (office e&m - established), 2,121 times for 458 patients. In total Naum Meyerovich billed 4,805 services in 25 codes, and Medicare paid $346K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,121 | 458 | $80.16 | $170K |
| 99212 Office E&M - Established | Office | 944 | 359 | $48.89 | $46K |
| 36415 Venipuncture Blood Collection | Office | 662 | 358 | $8.65 | $5,726 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 307 | 307 | $152.94 | $47K |
| 93000 Electrocardiogram | Office | 190 | 165 | $12.05 | $2,290 |
| G0008 Administration of influenza virus vaccine | Office | 77 | 77 | $36.42 | $2,804 |
| 90658 Vaccine Product | Office | 73 | 73 | $21.42 | $1,564 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 72 | 72 | $178.00 | $13K |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 70 | 67 | $108.40 | $7,588 |
| 93306 Echocardiography (TTE/TEE) | Office | 68 | 68 | $166.67 | $11K |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 52 | 44 | $245.79 | $13K |
| 93925 Duplex Scan - Extremity Arteries | Office | 42 | 42 | $231.84 | $9,737 |
| 93970 Duplex Scan - Extremity Veins | Office | 32 | 31 | $177.37 | $5,676 |
| 64445 Nerve Block Injection - Back | Office | 22 | 16 | $143.08 | $3,148 |
| 99203 Office E&M - New | Office | 18 | 18 | $81.77 | $1,472 |
By year: 2022 $392K for 5,581 services; 2023 $366K for 5,427 services; 2024 $346K for 4,805 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 662 | 358 | $8.65 | $5,726 |
Medicare prescription drug claims, 2024
In 2024, the drug Naum Meyerovich prescribed most often to Medicare patients was Metoprolol Succinate, with 1,168 prescriptions and refills. In total Naum Meyerovich wrote 30,253 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,168 | 1,463 | 183 | $9,143 |
| Vascepa Icosapent Ethyl | 1,061 | 1,105 | 130 | $364K |
| Rosuvastatin Calcium Generic | 906 | 1,186 | 150 | $4,757 |
| Linzess Linaclotide | 845 | 876 | 134 | $442K |
| Losartan Potassium Generic | 841 | 1,197 | 149 | $3,757 |
| Atorvastatin Calcium Generic | 817 | 1,088 | 129 | $3,034 |
| Metformin Hcl Generic | 703 | 909 | 109 | $2,523 |
| Omeprazole Generic | 646 | 778 | 132 | $2,877 |
| Amlodipine Besylate Generic | 567 | 747 | 103 | $1,405 |
| Myrbetriq Mirabegron | 515 | 525 | 63 | $228K |
| Creon Lipase/Protease/Amylase | 509 | 553 | 107 | $394K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 431 | 519 | 61 | $2,683 |
| Escitalopram Oxalate Generic | 431 | 489 | 72 | $1,982 |
| Tamsulosin Hcl Generic | 431 | 510 | 68 | $2,626 |
| Clopidogrel Clopidogrel Bisulfate | 425 | 559 | 63 | $1,682 |
Brand drugs: 8,624 claims; generic drugs: 21,262 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Naum Meyerovich $3,174 ($3,174 in general payments such as food, travel and fees) from 24 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $531.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 23 | $531 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 14 | $343 |
| Aimmune Therapeutics, Inc. | 6 | $300 |
| Teva Pharmaceuticals USA, Inc. TEVA | 14 | $266 |
| Abbvie Inc. ABBV | 10 | $259 |
| Neurocrine BioSciences, Inc. NBIX | 8 | $210 |
| Vanda Pharmaceuticals Inc. VNDA | 8 | $210 |
| Alkermes, Inc. ALKS | 8 | $178 |
| Harmony Biosciences LLC HRMY | 7 | $155 |
| Lundbeck LLC | 8 | $154 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.